Karen Dybkær

View Scopus Profile

Phone+4599403532
Emailk.dybkaerrndk, k_dybkaerdcm.aaudk

Søndre Skovvej 15, 330
9000 Aalborg
Denmark

Research activity per year

129 Journal article
48 Poster
39 Conference abstract in journal
27 Conference abstract for conference
More

5 results

Filter

2023

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Li, Y., Xu-Monette, Z. Y., Abramson, J., Sohani, A., Bhagat, G., Tzankov, A., Visco, C., Zhang, S., Dybkaer, K., Pan, Z., Xu, M., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Go, H., van Krieken, J. H., Winter, J. N., Ponzoni, M. & Ferreri, A. J. M. & 5 others, Møller, M. B., Piris, M. A., Wang, Y., Zhang, M. & Young, K. H., 11 Apr 2023, In: Blood advances. 7, 7, p. 1308–1311 4 p.
Research output: Contribution to journal › Letter › peer-review

Open Access
File

7 Citations (Scopus)

33 Downloads (Pure)
2020
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., Fang, X., Bhagat, G., Zhu, F., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Choi, W. W. L., Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B. & Parsons, B. M. & 9 others, van Krieken, J. H., Piris, M. A., Winter, J. N., Hagemeister, F., Alinari, L., Li, Y., Andreeff, M., Xu, B. & Young, K. H., 1 Dec 2020, In: Journal of Hematology & Oncology. 13, 1, 148.
Research output: Contribution to journal › Letter › peer-review

Open Access
File
32 Citations (Scopus)

39 Downloads (Pure)
2018

Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma
Bech, R. S., Nielsen, K. L., Larsen, T. S., Bentzen, H. H. N., Lynggaard, L. S., Do, T. H., Braendstrup, P., Brady, J., Mikhaeel, N. G., Dybkaer, K., Johnsen, H. E., Jensen, P., Bøgsted, M. & El-Galaly, T. C., 2018, In: British Journal of Haematology. 182, 2, p. 297-301 5 p.
Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)
2017
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
Visco, C., Wang, J., Tisi, M. C., Deng, L., D'Amore, E. S. G., Tzankov, A., Montes-Moreno, S., Dybkær, K., Bhagat, G., Hsi, E. D., van Krieken, J. H., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Medeiros, L. J., Xu-Monette, Z. Y. & Young, K. H., 2017, In: British Journal of Cancer. 117, 11, p. 1685-1688 4 p.
Research output: Contribution to journal › Letter › peer-review

Open Access
13 Citations (Scopus)
2015

Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma
El-Galaly, T. C., Bilgrau, A. E., Gaarsdal, E., Klausen, T. W., Pedersen, L. M., Nielsen, K. R., Bæch, J., Bøgsted, M., Dybkær, K., Johansen, J. S. & Johnsen, H. E., 2015, In: Leukemia and Lymphoma. 56, 8, p. 2476-2478 3 p.
Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Karen Dybkær

Research output

Search results

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma